Survey: Fewer than 50% of Enterprises Have Deployed Intelligent Automation Technology
86% of IT executives surveyed believe human work, AI systems, and robotic automation must be well-integrated by 2020 -- but only 12% said their companies do this really well today
RESTON, Va., March 12, 2019 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) announced the third set of findings from its Future of Work international survey
, conducted by IDG and LTM Research. Part three of the series looks specifically at “intelligent automation,” defined as the integration of emerging cognitive and robotic computing technologies into human-driven business processes and customer interactions. These technologies include artificial intelligence (AI), machine learning (ML), and robotic process automation (RPA). The data shows an enormous disconnect between the expected business benefits of intelligent automation and a typical organization’s ability to realize those benefits.
Less than half (46%) of organizations have deployed intelligent automation. This is despite the fact that a large majority of IT leaders agree that effective intelligent automation holds enormous potential for their businesses:
- 86% of executives surveyed say intelligent process integration will improve customer experience
- 68% say it will lead to improved customer satisfaction
- 92% say it will make the employee experience more rewarding
- 69% say it will lead to monetization of new revenue
IT leaders in enterprise organizations across North America and Europe feel tremendous urgency to take advantage of intelligent automation. However, the vast majority admit their companies can’t currently do it: 86% of executives interviewed indicated that human work, AI systems, and robotic automation “must be well-integrated by 2020,” yet only 12% of executives said their companies “do this really well today.”
Challenges: Complexity & Lack of Strategy
While there are deployments of individual emerging automation technologies, a lack of strategy and clear alignment to business goals is resulting in siloed deployments and overwhelmed internal application development teams. Less than half of surveyed companies have deployed any form of intelligent automation. Fully half of those companies boast IT staffs in excess of 20,000 employees. Specific pain-points include:
- 89% of respondents say their organizations struggle to adapt with technology
- 80% say their organizations “fail to understand how artificial intelligence would change everything”
- 66% have difficulty integrating existing IT investments and skills with demanding AI and RPA technology
- The need to change IT culture (44% ) and application development practices (31% ) were the next highest-ranked responses
To find out more about the state of intelligent automation, read the full Future of Work Survey Report, Part Three .
The Future of Work survey, conducted by IDG, gathered responses between August and September 2018. Respondents comprised of 500 IT leaders (50% C-level, all Director or above) at companies with over 1,000 employees. 50% of respondents were U.S. based, and 50% were from Europe (U.K., France, Germany, and Spain). For this leg of the survey, that data set was complemented by a 2019 survey of 100 North American IT executives that was conducted by LTM Research.
Appian provides a low-code development platform that accelerates the creation of high-impact business applications. Many of the world’s largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance.
For more press-related information, please contact:
Director of Media Relations
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Abeona Therapeutics Inc.21.5.2019 14:03:09 CEST | Pressemeddelelse
Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease
Invivoscribe, Inc.21.5.2019 12:02:33 CEST | Pressemeddelelse
Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies
GridGain Systems21.5.2019 09:02:54 CEST | Pressemeddelelse
GridGain Joins Cloud Native Computing Foundation
IMImobile21.5.2019 09:02:54 CEST | Pressemeddelelse
Telia Norway signs partner agreement with IMImobile for Enterprise cPaaS offering
Worksoft20.5.2019 17:56:04 CEST | Pressemeddelelse
Deutsche Telecom to Showcase How Intelligent Automation is Driving Quality and Program Efficiencies for ERP Transformation
Merus N.V.20.5.2019 14:41:11 CEST | Pressemeddelelse
Merus to Present at the RBC Capital Markets 2019 Healthcare Conference
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum